AAF
LEGN icon

Andra AP-fonden’s Legend Biotech LEGN Stock Holding History

Andra AP-fonden’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-63,600
Closed -$3.83M – 407
2023
Q4 		$3.83M Buy
63,600
+11,800
+23% +$748K 0.2% 189
2023
Q3 		$3.48M Buy
51,800
+14,000
+37% +$972K 0.21% 208
2023
Q2 		$2.61M Sell
37,800
-22,400
-37% -$1.46M 0.07% 506
2023
Q1 		$2.9M Sell
60,200
-10,700
-15% -$523K 0.08% 471
2022
Q4 		$3.54M Buy
70,900
+22,400
+46% +$1.09M 0.11% 405
2022
Q3 		$1.98M Buy
48,500
+13,200
+37% +$620K 0.06% 483
2022
Q2 		$1.94M Buy
+35,300
New +$1.49M 0.06% 506
2021
Q4 		$1.85M Buy
+39,600
New +$2.01M 0.04% 510

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Andra AP-fonden's LEGN Position: Q1 2024 in Review

Andra AP-fonden sold out of Legend Biotech (LEGN) in Q1 2024, closing a stake of 63,600 shares — an estimated $3.83M sold.

Andra AP-fonden first reported a position in LEGN in Q4 2021 and held it in 8 quarters. The position peaked at $3.83M in Q4 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Andra AP-fonden reported no remaining Legend Biotech position as of Q1 2024 after selling out during the quarter.
  • Andra AP-fonden sold 63,600 Legend Biotech shares in Q1 2024, an estimated $3.83M.
  • Andra AP-fonden first reported a position in Legend Biotech in Q4 2021 and held it in 8 quarters.
  • Andra AP-fonden's Legend Biotech position peaked at $3.83M in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Andra AP-fonden's 13F filing for Q1 2024, filed 13 May 2024.